98420336 - BESPAK

Information

  • Trademark
  • 98420336
  • Serial Number
    98420336
  • Registration Number
    7782740
  • Filing Date
    February 26, 2024
    2 years ago
  • Registration Date
    May 06, 2025
    10 months ago
  • Transaction Date
    May 07, 2025
    10 months ago
  • Status Date
    May 06, 2025
    10 months ago
  • Published for Opposition Date
    March 18, 2025
    a year ago
  • Location Date
    May 05, 2025
    10 months ago
  • Status Code
    700
  • Current Location
    FILE REPOSITORY (FRANCONIA)
    Employee Name
    GILLANI, MAHREEN
  • Attorney Docket Number
    066307.0069
    Attorney Name
    Shannon Marie McKeon
  • Owners
Mark Drawing Code
4
Mark Identification
BESPAK
Case File Statements
  • GS0411: Provision of training, teaching and educational services in the nature of workshops, lectures, classes and tutorials, all in the field of manufacturing, engineering, chemistry and pharmaceuticals; training services in the field of injection molding manufacturing; advisory, consultancy and information services relating to all the aforesaid
  • GS0401: Custom manufacture of medical devices for others; custom manufacture of medical devices to the order and specification of others, namely, inhalers and drug delivery devices sold empty, and pharmaceuticals; custom manufacture of components, parts and fittings for all the aforesaid products; management of product lifecycles for others, in the nature of custom manufacturing of medical devices to the order and specification of others, namely, inhalers and drug delivery devices sold empty, and pharmaceuticals; custom manufacturing of injection molded parts for others; custom manufacture of active pharmaceutical ingredients for others; custom manufacture of pharmaceuticals for others
  • GS0051: Pharmaceutical preparations and substances for the treatment of infectious, viral, bacterial, metabolic, endocrine, exocrine, muscular, skeletal, cardiovascular, respiratory, reproductive, digestive, excretory, renal, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, lymphatic, integumentary, nervous, hormonal, dermatological, psychiatric and immunological related diseases and disorders; Pharmaceutical products, namely, respiratory drugs for treating respiratory diseases and asthma; respiratory vaccines
  • GS0101: Drug delivery devices sold empty, namely, nasal inhalers for medical purposes, sold empty; pressurised metered dose inhalers (pMDI) for medical purposes, sold empty; nasal sprays for medical purposes; soft mist inhalers for medical purposes, sold empty; parts and fittings for all the aforesaid goods
  • GS0421: Research and development of medical apparatus and instruments for others; research and development of inhalers and design of prototyping services; metrology services; Research laboratory testing and analysis services in the field of prototyping, metrology, manufacturing, engineering, chemistry, medical and pharmaceuticals; product quality testing services; quality control advisory services namely regulatory quality control advisory of pharmaceuticals, active pharmaceuticals ingredients, medical apparatus and instruments, inhalers and drug delivery products, pharma and medical related products and apparatus and management of product lifecycles for others, namely, continuing scientific research in the nature of conducting and managing clinical trials and trials of medical apparatus and instruments, inhalers and drug delivery products, pharma and medical related products and apparatus; consulting services in the field of pharmaceutical research and development; consulting services in the field of drug delivery devices; advisory, consultancy and information services relating to all the foresaid
Case File Event Statements
  • 2/26/2024 - 2 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP
  • 7/2/2024 - a year ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 9/16/2024 - a year ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/16/2024 - a year ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/13/2024 - a year ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 9/16/2024 - a year ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 11/22/2024 - a year ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 11/22/2024 - a year ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 11/22/2024 - a year ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 1/2/2025 - a year ago
    13 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 1/2/2025 - a year ago
    11 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 1/2/2025 - a year ago
    12 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 1/2/2025 - a year ago
    10 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 1/2/2025 - a year ago
    14 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 1/22/2025 - a year ago
    15 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 1/28/2025 - a year ago
    17 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 3/12/2025 - a year ago
    18 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 3/18/2025 - a year ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 3/18/2025 - a year ago
    20 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 5/6/2025 - 10 months ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 5/6/2025 - 10 months ago
    22 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 1/28/2025 - a year ago
    16 - PUBLISHED FOR OPPOSITION Type: PUBO